<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22568" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hantavirus Pulmonary Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moore</surname>
            <given-names>Ross A.</given-names>
          </name>
          <aff>Southern Illinois University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Griffen</surname>
            <given-names>David</given-names>
          </name>
          <aff>Southern Illinois University SOM</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ross Moore declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>David Griffen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>4</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22568.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hantavirus pulmonary syndrome (HPS) is a rare yet serious pulmonary condition marked by pulmonary edema, hypoxia, and hypotension. HPS is caused by viruses of the&#x000a0;<italic toggle="yes">Orthohantavirus</italic>&#x000a0;genus and the Hantaviridae family. HPS presents with fevers, myalgia, and severe respiratory compromise, with up to 40% mortality. The most common etiology of HPS is the Sin Nombre virus in North America and the Andes virus in South America. Respiratory failure can be avoided through judicious fluid and volume management. The need for mechanical ventilation is common shortly upon disease onset. Care is primarily supportive, and prevention is key to disease reduction. Public health measures can best approach human-rodent contact reduction.&#x000a0;</p>
        <p>Within the activity, learners receive a comprehensive overview of HPS, including its epidemiology, etiology, clinical manifestations, diagnostic approaches, and management strategies. The course explores the latest research findings, providing insights into the pathophysiology of HPS and the mechanisms underlying its severe respiratory compromise. Additionally, learners explore the differences between HPS and hemorrhagic fever renal syndrome, ensuring a thorough understanding of both conditions. Practical guidance on preventive measures and public health interventions to reduce human-rodent contact are covered. Effective communication among team members is emphasized throughout the course, enabling seamless care coordination and implementing evidence-based practices.&#x000a0;Collaboration among diverse healthcare professionals ensures comprehensive patient care and effective preventive measures against this potentially fatal syndrome.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between Hantavirus pulmonary syndrome and other respiratory illnesses, particularly distinguishing this condition from similar febrile syndromes.</p></list-item><list-item><p>Implement appropriate supportive care measures promptly upon suspicion or confirmation of Hantavirus pulmonary syndrome, focusing on fluid and volume management to prevent respiratory failure.</p></list-item><list-item><p>Select and interpret appropriate diagnostic tests for Hantavirus pulmonary syndrome&#x000a0;confirmation, considering serological and molecular methods.</p></list-item><list-item><p>Coordinate multidisciplinary care involving infectious disease specialists, respiratory therapists, and critical care teams to optimize outcomes for patients with Hantavirus pulmonary syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22568&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22568">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22568.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hantavirus pulmonary syndrome (HPS) is a rare but severe pulmonary disease characterized by pulmonary edema, hypoxia, and hypotension. HPS is caused by viruses of the&#x000a0;<italic toggle="yes">Orthohantavirus</italic>&#x000a0;genus and the Hantaviridae family. Hantaviruses cause 2 main clinical presentations:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hemorrhagic fever renal syndrome is characterized by acute kidney injury, thrombocytopenia, fever, and hypotension. Found mainly in Asia, Eastern Russia, and parts of Europe, the primary causative virus species are&#x000a0;<italic toggle="yes">Hantaan, Dobrava, Seoul,&#x000a0;</italic>and&#x000a0;<italic toggle="yes">Puumala</italic>. Please see our companion StatPearls article, "Hemorrhagic Fever Renal Syndrome," for further information.<xref ref-type="bibr" rid="article-22568.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>Fever, myalgias, and severe respiratory compromise characterize HPS. Found mainly in North and South America, the primary causative virus species are&#x000a0;Sin Nombre&#x000a0;in North America and&#x000a0;Andes&#x000a0;in South America. Clinically, patients often require mechanical ventilation, and despite appropriate care, mortality is up to 40% (compared to 1%-15% for HFRS).<xref ref-type="bibr" rid="article-22568.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>Both syndromes involve the primary mechanism of virus inhalation, can affect the lungs and kidneys, and involve increased microvascular permeability, consumptive platelet coagulopathy, and hyperactivity of the host immune system. Over 24 known Hantaviridae are capable of causing human disease, and the virus type varies primarily by geographic location and animal vector. All types are carried by rodents (and shrews and bats, but rarely) and spread to humans through inhalation of aerosolized urine, feces, or animal bites. (The animals are asymptomatic carriers.) There is no known cure, and treatment is supportive. The highest risk of infection is seen in those who have close contact with animal hosts, and prevention is focused on decreasing human-rodent contact.<xref ref-type="bibr" rid="article-22568.r2">[2]</xref><xref ref-type="bibr" rid="article-22568.r3">[3]</xref><xref ref-type="bibr" rid="article-22568.r4">[4]</xref><xref ref-type="bibr" rid="article-22568.r5">[5]</xref></p>
        <p>Due to a plethora of newly sequenced viral genomic data, the taxonomy classifications were updated in 2016 to include Bunyavirales as an order, and the previous genus<bold>&#x000a0;</bold><italic toggle="yes">Hantavirus</italic>&#x000a0;became the family classification Hantaviridae.&#x000a0;<italic toggle="yes">Orthohantavirus</italic>&#x000a0;became the genus, and in this review, will be referred to as "Hantavirus."<xref ref-type="bibr" rid="article-22568.r6">[6]</xref></p>
      </sec>
      <sec id="article-22568.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hantaviruses were first discovered in the early 1950s by soldiers involved in the Korean War. They named the condition "Hantaan" because of the nearby Hantaan River, where most cases reportedly occurred. The most common virus strain in North America is the Sin Nombre virus, predominantly transmitted by the deer mouse (<italic toggle="yes">Peromyscus maniculatus</italic>) in the southwestern United States. This virus was found after a cluster of hantavirus cases occurred in 1993. In South America, the predominant strain is the Andes virus, which is especially virulent and the only strain known to cause human-to-human infection.<xref ref-type="bibr" rid="article-22568.r5">[5]</xref></p>
        <p>Hantaviruses (genus&#x000a0;<italic toggle="yes">Orthohantavirus</italic>) are enveloped, negative-sense, single-stranded ribonucleic acid (RNA) viruses. Components include a large viral segment encoding an RNA-dependent RNA polymerase, a glycoprotein precursor, and a nucleoprotein. The virion size ranges from 70 to 160 nm.<xref ref-type="bibr" rid="article-22568.r2">[2]</xref>&#x000a0;Hantaviruses infect endothelial, epithelial, dendritic, and lymphocyte cells by attaching the viral glycoprotein to the cell surface receptors.<xref ref-type="bibr" rid="article-22568.r7">[7]</xref></p>
        <p>Immature dendritic cells likely serve as carriers for the virus through lymphatic tissue and allow further viral replication once at the regional lymph nodes. In addition, once exposed to the endothelial cells, immune activation is induced, especially by CD8+ T cells and macrophages.</p>
        <p>Hantaviruses induce the maturation of infected dendritic cells and elicit a profound T-cell response in the acute infection phase, unlike other hemorrhagic fever viruses that inhibit dendritic cell maturation.<xref ref-type="bibr" rid="article-22568.r3">[3]</xref></p>
        <p>Critical adhesive receptors, beta-3 integrins, regulate platelet activation and vascular permeability and mediate hantaviruses' cellular entry. Invasion of the endothelium is believed to induce interferon-alpha (IFN-&#x003b1;), which is possibly the cause of the prodromal manifestations. Once the infection has progressed, immunoblasts may be seen in the peripheral blood smear. T cell clones will be hantavirus-specific. Activated macrophages, in conjunction with these immunoblasts, will migrate to the interstitium of the lung. Capillary endothelial permeability greatly increases after the secretion of tumor necrosis factor-alpha (TNF-&#x003b1;), IFN-&#x003b3;, and nitric oxide, which results in pulmonary edema. Soluble mediators such as TNF-&#x003b1;, IFN-&#x003b3;, and nitric oxide are suggested as etiologies of myocardial depression in this infection, resulting in cardiogenic shock.</p>
      </sec>
      <sec id="article-22568.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>HPS is the primary form of Hantavirus syndrome in North and South America. In the United States, sporadic cases of Hantavirus have been seen as far east as Maine, but most of the 697 cases (as of January 2017) were west of the Mississippi River. Seven states account for approximately 70% of all cases reported in the United States, with the most cases in New Mexico (109 cases), Colorado (104 cases), Arizona (77 cases), California (63 cases), Washington (47 cases), Texas (42 cases), and Montana (41 cases).</p>
        <p>The following list of Hantavirus presentations contains the virus serotype, specific rodent vector, and geographic distribution:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sin Nombre Virus:&#x000a0;<italic toggle="yes">Peromyscus maniculatus,</italic>&#x000a0;Canada, United States&#x02014;the major cause of Hantavirus in Canada and the United States</p>
          </list-item>
          <list-item>
            <p>New York Virus;&#x000a0;<italic toggle="yes">Peromyscus leucopus,</italic>&#x000a0;eastern United States</p>
          </list-item>
          <list-item>
            <p>Monongahela Virus:&#x000a0;<italic toggle="yes">Peromyscus maniculatus nubiterrae,</italic>&#x000a0;eastern United States</p>
          </list-item>
          <list-item>
            <p>Bayou Virus: Oryzomys palustris, southeastern United States</p>
          </list-item>
          <list-item>
            <p>Black Creek Canal Virus:&#x000a0;<italic toggle="yes">Sigmodon hispidus,</italic>&#x000a0;Florida, United States</p>
          </list-item>
          <list-item>
            <p>Laguna Negra:&#x000a0;<italic toggle="yes">Calomys laucha,</italic>&#x000a0;Paraguay, Bolivia&#x02014;first South American Hantavirus isolated</p>
          </list-item>
          <list-item>
            <p>Andes:&#x000a0;<italic toggle="yes">Oligoryzomys longicaudatus,</italic>&#x000a0;Argentina, Chile, Uruguay&#x02014;only Hantavirus with a person-to-person transmission reported</p>
          </list-item>
          <list-item>
            <p>Oran:&#x000a0;<italic toggle="yes">Oran longicaudatus;</italic>&#x000a0;northern Argentina&#x02014;regularly causes disease in cane-growing areas</p>
          </list-item>
          <list-item>
            <p>Choclo:&#x000a0;<italic toggle="yes">Oligoryzomys fulvescens,</italic>&#x000a0;Panama</p>
          </list-item>
          <list-item>
            <p>Rio Mamore:&#x000a0;<italic toggle="yes">Neacomys spinosus,</italic>&#x000a0;Peru</p>
          </list-item>
          <list-item>
            <p>Lechiguanas:&#x000a0;<italic toggle="yes">Oligoryzomys flavescens,</italic>&#x000a0;Argentina</p>
          </list-item>
        </list>
        <p>The literature suggests that around 50% of infections are due to exposure in or around the home, 10% from the workplace, and 5% during recreation. The rest of the exposures are from mixed or unknown causes.<xref ref-type="bibr" rid="article-22568.r3">[3]</xref></p>
      </sec>
      <sec id="article-22568.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Pathophysiology of HPS includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Inhalation of the infectious virus can result in viral deposition in the alveoli or terminal bronchioles. Viremia is likely generated after infection of alveolar macrophages or other primary targets, resulting in widespread infection of the pulmonary capillary endothelium.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Replication within the vascular endothelium does not have direct cytopathic effects. Instead, tissue injury appears due to the immune response and viral replication.</p>
          </list-item>
          <list-item>
            <p>Increased viral RNA causes a cytokine storm, ultimately leading to vascular permeability and pulmonary edema.</p>
          </list-item>
          <list-item>
            <p>Upon the development of pulmonary edema, multiorgan failure may ensue.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22568.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients usually present after contact with rodents, feces, or a rodent bite. Farmers, those in forestry occupations, or people with a history of cleaning rodent-infested areas are especially vulnerable. Those who have close contacts of such persons are also at risk. Initial complaints are often flu-like and nonspecific.<xref ref-type="bibr" rid="article-22568.r8">[8]</xref>&#x000a0;</p>
        <p>Normal presentation is around 7 to 39 days after viral exposure, and initial symptoms include a prodrome of headache, myalgia, vomiting, and abdominal pain. About 3 to 6 days after the initial prodromal phase, respiratory compromise can quickly develop, involving dyspnea, pulmonary edema, hypotension, and shock.<xref ref-type="bibr" rid="article-22568.r2">[2]</xref>&#x000a0;Respiratory compromise often occurs within 48 hours and rapidly turns into respiratory failure. Bilateral, diffuse interstitial pulmonary edema is characteristically seen radiographically. Cardiovascular collapse is possible during this stage.<xref ref-type="bibr" rid="article-22568.r4">[4]</xref>&#x000a0;Patients often develop metabolic acidosis due to severe infection. Descent into the pulmonary syndrome carries a mortality rate of around 50% to 70%.<xref ref-type="bibr" rid="article-22568.r9">[9]</xref>&#x000a0;Other possible signs are decreased urine output, petechiae, and hemorrhage.</p>
      </sec>
      <sec id="article-22568.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A chest x-ray may demonstrate bilateral pulmonary edema on the initial radiograph in about one-third of patients; however, nearly all patients will have findings of interstitial edema at 48 hours after admission. Almost two-thirds of patients will develop bibasilar opacities or perihilar opacities with some degree of pleural effusions.</p>
        <p>Thrombocytopenia may be present on blood count once admission is necessary for staging the disease and helps predict disease progression.<xref ref-type="bibr" rid="article-22568.r8">[8]</xref>&#x000a0;Other critical laboratory findings include circulating immunoblasts, atypical lymphocytes, and elevated hematocrit. Once the patient needs hospitalization, a peripheral blood smear may demonstrate myelocytes, metamyelocytes, and promyelocytes with severe thrombocytopenia and hypocapnia. Hyponatremia may also be present along with slightly prolonged activated partial thromboplastin time, a decreased protein level, mildly elevated low-density lipoprotein level, and microscopic hematuria.&#x000a0;Diagnosis can be made by immunofluorescent or immunoblot assay. An enzyme-linked immunosorbent assay utilizing immunoglobulin M is preferred. Quantitative polymerase chain reaction is also an option.<xref ref-type="bibr" rid="article-22568.r3">[3]</xref></p>
      </sec>
      <sec id="article-22568.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is supportive (namely, with aggressive cardiopulmonary support). Key treatment features are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Symptom intensity often drives patients to seek medical attention, but lack of significant findings necessitating admission often results in supportive care for discharge.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Respiratory failure can be severe, with around 40% of cases requiring mechanical ventilation.</p>
          </list-item>
          <list-item>
            <p>Extracorporeal membrane oxygenation for advanced HPS has been used at the University of New Mexico with a 70% success rate if intervention was early. However, given the condition's rarity, clinical trials cannot establish efficacy.<xref ref-type="bibr" rid="article-22568.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Despite appropriate treatment in intensive care units, around one-third of patients will die in the first 48 hours after admission.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Almost half of the patients admitted with Hantavirus will not require mechanical ventilation via intubation if appropriately managed with judicious fluids and close monitoring.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ribavirin has been proposed as a treatment option with some benefit to inhaled ribavirin; overall effectiveness has yet to be proven.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Fluid balance should be attempted to maintain normal-high filling pressures for cardiac output and minimize pulmonary edema.</p>
          </list-item>
          <list-item>
            <p>Inotropic agents such as dobutamine are encouraged early.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Death is often associated with disseminated intravascular coagulation, which includes frank hemorrhage and drastic leukocytosis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Should patients improve in the first few days, there is a good probability of extubation within the first week.</p>
          </list-item>
          <list-item>
            <p>Vaccines have been used in China and Korea, but long-term results are unavailable.<xref ref-type="bibr" rid="article-22568.r9">[9]</xref><xref ref-type="bibr" rid="article-22568.r10">[10]</xref><xref ref-type="bibr" rid="article-22568.r11">[11]</xref><xref ref-type="bibr" rid="article-22568.r12">[12]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22568.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Acute Respiratory Distress Syndrome&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute onset of dyspnea with bilateral chest x-ray non-cardiogenic infiltrates and partial pressure of oxygen in arterial blood/fraction of inspiratory oxygen concentration (PaO<sub>2</sub>/FiO<sub>2</sub>) less than 300.</p>
          </list-item>
          <list-item>
            <p>There is difficulty delineating acute respiratory distress syndrome from Hantavirus.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The inciting factors must be evaluated.</p>
          </list-item>
          <list-item>
            <p>Management is similar in terms of respiratory support.</p>
          </list-item>
        </list>
        <p>
<bold>Mycobacterial Pneumonia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>If the patient requires mechanical ventilation and bronchoalveolar lavage is obtained, other presenting pathogens may guide antibiotic therapy.</p>
          </list-item>
          <list-item>
            <p>Broad-spectrum antibiotic treatment has not been shown to change the outcomes of Hantavirus for better or worse.</p>
          </list-item>
        </list>
        <p>
<bold>Influenza Pneumonia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Influenza polymerase chain reaction (PCR) helps rule in influenza pneumonia instead of Hantavirus.</p>
          </list-item>
        </list>
        <p>
<bold>Viral Hemorrhagic Fevers</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Specific PCRs are necessary to diagnose a single etiology.</p>
          </list-item>
          <list-item>
            <p>Treatment is supportive care in the intensive care unit.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22568.s10" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Pertinent studies include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fresh frozen plasma from patients who have recovered from HPS has been used with good effect (eg, results from a study showed a decrease in mortality from 32% to 14%).<xref ref-type="bibr" rid="article-22568.r2">[2]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Animal studies are being conducted that use recombinant antibodies to the Hantavirus.<xref ref-type="bibr" rid="article-22568.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Hantavax has been used in Asia since the 1990s; this is believed to effectively decrease the incidence of new cases.<xref ref-type="bibr" rid="article-22568.r13">[13]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22568.s11" sec-type="Staging">
        <title>Staging</title>
        <p>By the time a patient requires hospitalization, transformation into the second stage of the disease has most likely already developed, with cough and vomiting dominating the clinical presentation. Orthostatic hypotension, tachycardia, and tachypnea will likely all be present. Platelet count is the first significant abnormal laboratory test, which is also the most useful. Thrombocytopenia or decreasing platelet count warrants admission to the hospital for further evaluation. Hematuria has been noted as a marker of kidney injury but has not been correlated with thrombocytopenia.<xref ref-type="bibr" rid="article-22568.r14">[14]</xref><xref ref-type="bibr" rid="article-22568.r15">[15]</xref><xref ref-type="bibr" rid="article-22568.r16">[16]</xref></p>
      </sec>
      <sec id="article-22568.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Despite appropriate treatment in the intensive care unit, around one-third of patients will die in the first 48 hours after admission. However, almost half of the patients admitted with Hantavirus will not require mechanical ventilation via intubation if appropriately managed with judicious fluids and close monitoring.Should patients improve within the first few days, there is a good probability of extubation within the first week, and there are often no major long-term complications. However, subjective complaints of dyspnea, fatigue, and myalgias may occur. Higher titers of antibodies neutralizing the viral nucleocapsid immune complexes correlate with a higher likelihood of survival.</p>
      </sec>
      <sec id="article-22568.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Hantavirus does not affect children as dramatically as it does adults.<xref ref-type="bibr" rid="article-22568.r17">[17]</xref></p>
      </sec>
      <sec id="article-22568.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hantavirus is a lethal infection, and despite optimal treatment, mortality rates are high. Because the infection can involve many organs, this condition is best managed by an interprofessional team, including infectious disease, hematology, neurology, pulmonology, and intensivists. The intensive care management team is key because care is largely supportive. Primary providers, respiratory care therapists, intensive care unit nursing staff, and pharmacists are important players. Prevention is of primary importance in this disease, and public health officials are best suited to institute the needed measures. These measures include decreasing human-rodent contact and using protective gear when such contact is unavoidable.&#x000a0;</p>
        <p>Minimizing human-rodent contact is the best approach to prevention. Pest control and removal of rodents from living areas are important. Ventilating homes and allowing natural light into the area to neutralize the virus by ultraviolet light may prevent the spread of the infection. Public health measures include protective gear when dealing with rodents and rodent feces.&#x000a0;</p>
      </sec>
      <sec id="article-22568.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22568&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22568">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/hantavirus-pulmonary-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22568">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22568/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22568">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22568.s16">
        <title>References</title>
        <ref id="article-22568.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Romero</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Rout</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hashmi</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Anjum</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <chapter-title>Hemorrhagic Fever Renal Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>11</month>
            <day>5</day>
            <pub-id pub-id-type="pmid">32809495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saavedra</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>D&#x000ed;az</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Retamal-D&#x000ed;az</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Covi&#x000e1;n</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kalergis</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.</article-title>
            <source>Immunology</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>163</volume>
            <issue>3</issue>
            <fpage>262</fpage>
            <page-range>262-277</page-range>
            <pub-id pub-id-type="pmid">33638192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chandy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mathai</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Globally emerging hantaviruses: An overview.</article-title>
            <source>Indian J Med Microbiol</source>
            <year>2017</year>
            <season>Apr-Jun</season>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>165</fpage>
            <page-range>165-175</page-range>
            <pub-id pub-id-type="pmid">28681802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koehler</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Di Cristanziano</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sp&#x000e4;th</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Hoyer-Allo</surname>
                <given-names>KJR</given-names>
              </name>
              <name>
                <surname>Wanken</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>RU</given-names>
              </name>
              <name>
                <surname>Burst</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The kidney in hantavirus infection-epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management.</article-title>
            <source>Clin Kidney J</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>7</issue>
            <fpage>1231</fpage>
            <page-range>1231-1252</page-range>
            <pub-id pub-id-type="pmid">35756741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maleki</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iglesias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ciancaglini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hammar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ljunggren</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Schierloh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Klingstr&#x000f6;m</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Serum Markers Associated with Severity and Outcome of Hantavirus Pulmonary Syndrome.</article-title>
            <source>J Infect Dis</source>
            <year>2019</year>
            <month>May</month>
            <day>05</day>
            <volume>219</volume>
            <issue>11</issue>
            <fpage>1832</fpage>
            <page-range>1832-1840</page-range>
            <pub-id pub-id-type="pmid">30698699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laenen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vergote</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Calisher</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Klempa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Klingstr&#x000f6;m</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kuhn</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Maes</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title><italic>Hantaviridae</italic>: Current Classification and Future Perspectives.</article-title>
            <source>Viruses</source>
            <year>2019</year>
            <month>Aug</month>
            <day>27</day>
            <volume>11</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">31461937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Av&#x00161;i&#x0010d;-&#x0017d;upanc</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saksida</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Korva</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hantavirus infections.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>21S</volume>
            <fpage>e6</fpage>
            <page-range>e6-e16</page-range>
            <pub-id pub-id-type="pmid">24750436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vial</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Graf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Calvo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferr&#x000e9;s</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mertz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cuiza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ag&#x000fc;ero</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aguilera</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Araya</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pailamilla</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Paratori</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Torres-Torres</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vial</surname>
                <given-names>PA</given-names>
              </name>
              <collab>Hantavirus Study Group in Chile</collab>
            </person-group>
            <article-title>Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome.</article-title>
            <source>Viruses</source>
            <year>2019</year>
            <month>Jul</month>
            <day>30</day>
            <volume>11</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31366116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drebot</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grolla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Safronetz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kobinger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lindsay</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Hantavirus pulmonary syndrome in Canada: An overview of clinical features, diagnostics, epidemiology and prevention.</article-title>
            <source>Can Commun Dis Rep</source>
            <year>2015</year>
            <month>Jun</month>
            <day>04</day>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>124</fpage>
            <page-range>124-131</page-range>
            <pub-id pub-id-type="pmid">29769944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Curtis</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Milholland</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Schountz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Castro-Arellano</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mali</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Detection of New World Hantavirus Antibodies in Rodents of Eastern New Mexico, USA.</article-title>
            <source>J Wildl Dis</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>986</fpage>
            <page-range>986-989</page-range>
            <pub-id pub-id-type="pmid">31021684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>XR</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>XJ</given-names>
              </name>
            </person-group>
            <article-title>Severe fever with thrombocytopenia syndrome can masquerade as hemorrhagic fever with renal syndrome.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>e0007308</fpage>
            <pub-id pub-id-type="pmid">30925154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>No</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Wiley</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Chain</surname>
                <given-names>PSG</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Palacios</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Active Targeted Surveillance to Identify Sites of Emergence of Hantavirus.</article-title>
            <source>Clin Infect Dis</source>
            <year>2020</year>
            <month>Jan</month>
            <day>16</day>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>464</fpage>
            <page-range>464-473</page-range>
            <pub-id pub-id-type="pmid">30891596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Vaccines and Therapeutics Against Hantaviruses.</article-title>
            <source>Front Microbiol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>2989</fpage>
            <pub-id pub-id-type="pmid">32082263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Outinen</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Mantula</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Laine</surname>
                <given-names>OK</given-names>
              </name>
              <name>
                <surname>P&#x000f6;rsti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vaheri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>M&#x000e4;kel&#x000e4;</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Mustonen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Haematuria is a marker for the severity of acute kidney injury but does not associate with thrombocytopenia in acute Puumala hantavirus infection.</article-title>
            <source>Infect Dis (Lond)</source>
            <year>2017</year>
            <season>Nov-Dec</season>
            <volume>49</volume>
            <issue>11-12</issue>
            <fpage>840</fpage>
            <page-range>840-846</page-range>
            <pub-id pub-id-type="pmid">28762841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clement</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>LeDuc</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>McElhinney</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Reynes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Van Ranst</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calisher</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics of Ratborne Seoul Hantavirus Disease.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>387</fpage>
            <page-range>387-388</page-range>
            <pub-id pub-id-type="pmid">30666956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guterres</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Lemos</surname>
                <given-names>ERS</given-names>
              </name>
            </person-group>
            <article-title>Hantaviruses and a neglected environmental determinant.</article-title>
            <source>One Health</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>5</volume>
            <fpage>27</fpage>
            <page-range>27-33</page-range>
            <pub-id pub-id-type="pmid">29911161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22568.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dzagurova</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Tkachenko</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ishmukhametov</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Balovneva</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Klempa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kruger</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Severe hantavirus disease in children.</article-title>
            <source>J Clin Virol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>101</volume>
            <fpage>66</fpage>
            <page-range>66-68</page-range>
            <pub-id pub-id-type="pmid">29428460</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
